Recently Updated Pages
Glossary
Cede Review An institution agrees to transfer IRB review and oversight authority for specified re...
IRB News & Updates
New Biomedical/Social Behavioral IRB Application Rollout Oct 30th, 2025 The new version of the Bi...
sIRB - Submission deadlines
Click here to be redirected to the page for sIRB Submission Deadlines for New Submissions, Previo...
Introduction
Mailing Address: Institutional Review Board University of Nebraska Medical Center 98783...
8.1 Review of Adverse Events and Adverse Device Effects
Last Revised: 3/24/2026 1.0 Purpose The purpose of this policy is to describe the process for rep...
5.3 Use of a Remote Consent Process
Last Revised: 1/14/2026 For an abbreviated version intended for investigators, coordinators, and ...
1.17 Retention of Research Records
Last Revised: 12/17/2025 For an abbreviated version intended for investigators, coordinators, and...
1.1 Human Research Protection Program (HRPP)
Last Revised: 2/18/2026 1.0 Purpose The purpose of this policy is to provide a basic description ...
1.29 ClinicalTrials.gov Reporting
Last Revised: 3/9/2026 1.0. Purpose The purpose of this policy is to describe the requirements fo...
1.19 IRB Signature Authority
Last Revised: 2/18/2026 1.0 Purpose The purpose of this policy is to describe the Organization’s ...
Table of Contents
Section 1: General Human Research Protection Program Polices 1.1 Human Research Protection Progra...
1.24 HRPP Training Requirements for IRB Members and IRB Analysts
Last Revised: 3/4/2026 1.0 Purpose The purpose of this policy is to describe the Organization’s r...
1.6 IRB Composition, Leadership, Qualifications, and Responsibilities
Last Revised: 2/15/2025 1.0 Purpose The purpose of this policy and procedure is to describe the O...
3.3 Privacy Interests and Confidentiality of Research Data
Last Revised 1/21/2024 For an abbreviated version intended for investigators, coordinators, and s...
1.8 Investigational Activities Requiring IRB Review and Approval
Last Revised: 5/9/2023 For an abbreviated version intended for investigators, coordinators, and s...
3.13 Use of Placebo or Wash-Out of Effective Therapy in Clinical Trials
Last Revised: 2/7/2018 For an abbreviated version intended for investigators, coordinators, and s...
5.4 Waiver of Requirement to Obtain Signed Consent Form
Last Revised: 12/11/2024 For an abbreviated version intended for investigators, coordinators, and...
5.2 Waiver or Alteration of Informed Consent and HIPAA Authorization
Last Revised: 2/7/2024 For an abbreviated version intended for investigators, coordinators, and s...
4.1 Additional Protections for Vulnerable Persons
Last Revised: 4/16/2025 For an abbreviated version intended for investigators, coordinators, and ...
3.4 Use of Protected Health Information in Research
Last Revised: 4/9/2018 For an abbreviated version intended for investigators, coordinators, and s...